Oncology News | pharmaphorum

News

CARGO eyes $300m IPO against lacklustre listings backdrop

CARGO Therapeutics has said it plans to offer around 18.8 million shares in the latest bid by a biotech to list on the Nasdaq, amid a desultory year for initial public off

News

Gilead, Arcus say TIGIT combo encouraging in GI cancer

Gilead and Arcus’ efforts to rebuild confidence in TIGIT as a drug target for cancer immunotherapies have shuffled forwards again, with new data showing signs of efficacy

News

Generic breast cancer drug cleared for prevention in England

Almost 30 years after it was first licensed as a treatment for breast cancer, aromatase inhibitor anastrozole has been cleared for preventive use in women at high risk of

News

BMS extends its position in ADCs with $180m Orum deal

Bristol-Myers Squibb has signed another deal to build its capabilities in antibody-drug conjugates for cancer, paying $100 million upfront to take control of an Orum Thera

News

Study finds higher cancer rate in patients given ‘all clear’

An intriguing UK study has found that people who get urgent referrals for suspected cancer, but were found not to have cancer after all, had a higher-than-expected risk ov

News

Kronos sheds staff despite positive data for cancer drug

A positive clinical trial is usually a signal for a biotech startup to press the accelerator on its spending, but Kronos Bio is taking a different tack.

CARGO eyes $300m IPO against lacklustre listings backdrop

Gilead, Arcus say TIGIT combo encouraging in GI cancer

Generic breast cancer drug cleared for prevention in England

BMS extends its position in ADCs with $180m Orum deal

Study finds higher cancer rate in patients given ‘all clear’

Kronos sheds staff despite positive data for cancer drug

CMS aims for broader GLP-1 access via federal programmes

How to meet your physicians where they are online

News

Editor's Picks